Schmidt WK

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative - Hammock_2021_J.Med.Chem__
Author(s) : Hammock BD , McReynolds CB , Wagner K , Buckpitt A , Cortes-Puch I , Croston G , Lee KSS , Yang J , Schmidt WK , Hwang SH
Ref : Journal of Medicinal Chemistry , : , 2021
Abstract : Hammock_2021_J.Med.Chem__
ESTHER : Hammock_2021_J.Med.Chem__
PubMedSearch : Hammock_2021_J.Med.Chem__
PubMedID: 33550801

Title : Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis - McReynolds_2019_Front.Pharmacol_10_533
Author(s) : McReynolds CB , Hwang SH , Yang J , Wan D , Wagner K , Morisseau C , Li D , Schmidt WK , Hammock BD
Ref : Front Pharmacol , 10 :533 , 2019
Abstract : McReynolds_2019_Front.Pharmacol_10_533
ESTHER : McReynolds_2019_Front.Pharmacol_10_533
PubMedSearch : McReynolds_2019_Front.Pharmacol_10_533
PubMedID: 31214021

Title : Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases - Wagner_2017_Pharmacol.Ther_180_62
Author(s) : Wagner KM , McReynolds CB , Schmidt WK , Hammock BD
Ref : Pharmacol Ther , 180 :62 , 2017
Abstract : Wagner_2017_Pharmacol.Ther_180_62
ESTHER : Wagner_2017_Pharmacol.Ther_180_62
PubMedSearch : Wagner_2017_Pharmacol.Ther_180_62
PubMedID: 28642117